MKI67 and lung carcinoma: Although, it is known that the nuclear antigen recognized by Ki-67 antibody provides a reliable method for evaluating tumor growth fraction in lung cancer, it is expressed during the G1, S, G2, and M phases of the cell cycle [29] making impossible to distinguish between S-phase and mitosis.